InvestorsHub Logo
Followers 18
Posts 1135
Boards Moderated 0
Alias Born 11/21/2017

Re: skitahoe post# 198518

Sunday, 11/18/2018 1:50:45 PM

Sunday, November 18, 2018 1:50:45 PM

Post# of 725431
Curing mice is quite a difference from a phase 3 successful therapy against the most deadly form of cancer. This isn’t a cure. But it’s a MAJOR advancement. And it’s not just a drug. It’s a platform. NWBO was WAY oversold for too long. While shorts might not get out for good until we get over $5, it is clear that this platform works in a space that has confounded scientists for years. There is more work to do, but NWBO could end up having a monopoly on the solid tumor treatment space for decades. Think lung cancer. Pancreatic. Ovarian. Breast. NO side effects. Just the immune system fixing a mutation. Combine it with checkpoint inhibitors for more efficacy.

Patients have deserved this for too long.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News